Largest Verdict in a Personal Injury case
in Pennsylvania history
Largest-ever compensatory verdict
Then-second largest Product
Liability verdict in U.S. history
Auto Accident Verdict
Largest single-victim fatality settlement
Civil Rights verdict
- Watch Here For Kline & Specter News Alerts
- On TV ⇒ Kline & Specter files suit in unnecessary stent procedure case
- Suit filed in Seton Hill University bus crash
- Firm wins record $105 million settlement in power line death case
- On TV ⇒ Tom Kline comments on possible PSU victim settlements
- Tom Kline argues before appellate panel vs. cap on jury awards
- Specter, Baldwin, Guerrini $109 million verdict among U.S.Top 10
- On TV ⇒ Tom Kline comments on kidnap case
- Tom Kline named 2013 Best Philadelphia Medical Malpractice Lawyer
- Seven at Kline & Specter named "Best Lawyers in America"
- Specter sues city over captivity and torture of 10-year-old girl
- High Court refuses case, $8.75M verdict vs. Ford stands
- Kline & Specter files suit on behalf of Eagles' Jason Peters
- Eleven at Kline & Specter selected as "Super Lawyers"
- Tom Kline named No. 1 PA lawyer 9th straight year
- Kline & Specter Courtroom dedicated at Penn Law School
- Waldenberger wins $3M verdict in cancer case
- On TV ⇒The Kline & Specter Squash Center opens at Drexel University
- Kline, Caputo win $14M verdict in Pennsbury school bus accident case
- On TV ⇒ Tom Kline interviewed on Penn State case by CNN, MSNBC ...
- Kline & Specter named No. 1 Product Liability Firm in the United States
- Specter, Safier, Williams win $17.5M med-mal verdict
- On TV ⇒ Shanin Specter comments on the Ellison case, CBS3
- Guerrini wins $15M verdict in teen's death
- Specter featured on Super Lawyers magazine cover
- Tom Kline again No. 1 in PA, firm has nine named Super Lawyers
- PA Superior Court panel upholds $8.75M Blumer verdict
- Kline & Specter wins largest-ever Erie personal injury verdict, $21.6M
- Michael Smerconish joins Kline & Specter
- On TV ⇒ Kline, Inscho, Baldwin obtain $1.8M in psychologist sex case
- Kline & Specter named among Best Law Firms in U.S.
- Trunk, Zakeosian win $11.7 million against PHA and property manager
- Kline, Specter named among nation's 500 "Leading Lawyers"
- On TV ⇒ ESPN features the Plevretes case, Shanin Specter
- Best Lawyers names Tom Kline No. 1 Phila. personal injury attorney
- See more Kline & Specter stories in the news
Defective Medical Devices Attorneys: Guidant - Medtronic - Baxter Products
Pennsylvania - New Jersey - Delaware - New York - Nationwide
Defibrillators - Pacemakers - Stents - Baxter Pumps
Thousands of patients have been injured over the years by malfunctioning medical devices. These defective or problematic devices range from stents, Guidant defibrillators and pacemakers to hip replacements and Baxter medicine pumps. Sometimes a device-related injury, even death, can occur during an implant procedure while in other instances an injury can go undiscovered for years.
If you had a loved one who died because of a defective medical device, you may need an attorney with the experience to handle a potential lawsuit. Kline & Specter, P.C., based in Philadelphia and with more than 30 lawyers (several of them also highly regarded doctors) has successfully litigated many product liability and mass tort cases, particularly in Pennsylvania, New Jersey and Delaware. We are currently handling a number of cases involving patients who used Guidant Corp. and Medtronic Inc. products. Click here to contact an attorney.
Guidant announced on Sept. 23 that it was recalling 170,000 Insignia and Nexus pacemakers due to malfunctions. The devices were subject to sudden loss -- both intermittent and permanent -- of pacing output or loss of telemetry without warning. Learn more...
Guidant and Medtronic have acknowledged problems with cardiac defibrillators implanted in patients. Guidant in June 2005 voluntarily recalled almost 50,000 of the devices because certain models contained a flaw that caused some units to short-circuit and malfunction, resulting in at least two reported deaths and potentially many more. Learn more...
Two types of stents have come under recent scrutiny -- drug-eluting stents made by Boston Scientific Corp. and Johnson & Johnson and the Ancure endograft, whose sales have already been halted by manufacturer Endovascular Technologies.
There is concern that the drug-coated stents may cause blood clotting and resulting heart attacks. Some physicians and studies estimate that the widely used stents -- millions have been used in recent years -- may kill more than 2,000 Americans a year.
The Ancure endograft has produced more than 2,600 complaints and has been linked to at least 28 deaths. The device is produced by Endovascular Technologies, a subsidiary of Guidant Corp., which pleaded guilty in June 2003 of concealing the vast majority of reported problems with its stent from the government. Sales of the device have been halted. Learn more about stents ...
Baxter Medicine Pumps
Kline & Specter, P.C., has had excellent results with lawsuits involving defective products, especially those filed in Pennsylvania, New Jersey and Delaware but also others across the nation. (See our Major Victories.)
- Few patients are aware of a deep financial relationship their doctor may have with medical device companies and how that may influence their care. The Star Tribune examines the practice of medical device payments to doctors, and the ethical and legal issues engulfing it. (Full story)
- In Massachusetts, a 15-year-old boy with cerebral palsy dies when the backup battery on his ventilator failed during an early-morning power outage. The tragic ventilator death comes 16 months after a 2-year-old Illinois boy died when a machine made by the same manufacturer also failed. The company has issued four ventilator recalls in 2002 and 2004, including one that involved a backup battery malfunction that may have led to one death. (Full story)
- CT heart scans, a relatively recent innovation in medicine, have never been proven to be better than older or cheaper tests and are perhaps being used more and more on patients by doctors seeking to recoup their investment in the devices. The scans may also pose a cancer risk. (Full story)
- The Heart Rhythm Society said today that the FDA should tighten up post-market surveillance of pacemakers and implantable cardioverter defibrillators. (Full story)